Vytala was founded by Jim O'Connell in 2022.

Who are Vytala's investors?

Vytala's investors include Delaware Crossing Investor Group, Robin Hood Ventures, The MBA Fund, Ulu Ventures.

Vytala

Founded 2022 · 18 employees on LinkedIn · 4 known investors

Find your way into Vytala

Each arrow is one introduction. Sign up to fill in the first one.

1,447 people can intro you to Jim

Ask Steve Reale to introduce you to Jim O'Connell

You →Steve · together at Vytala →Jim

Your email: who you already know at Vytala, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vytala team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Vytala is a foodtech company that develops nutrition solutions to address fat malabsorption and other nutrient deficiencies. The company focuses on clinical nutrition with an emphasis on improving health outcomes through innovative food science.

Biotech Digital Health FoodTech Healthtech Medical Devices

Founders & leadership

Vytala was founded in 2022 by Jim O'Connell.

Jim O'Connell CEO and FounderJim O'Connell is the founder of Vytala, a nutrition company developing structured lipids to address fat malabsorption and nutrient deficiencies. He brings 25+ years of experience in startups and Fortune 500 companies, along with board and advisory roles at various organizations.

Investors · 4

Delaware Crossing Investor Grouplisted by Delaware Crossing Investor GroupPhiladelphia

How we know: Delaware Crossing Investor Group's portfolio page · press coverage · Not right? Tell us

Robin Hood Ventureslisted by Robin Hood VenturesPhiladelphia · $250K – $1Mvia Pitou Devgon · inferred

How we know: press coverage · Not right? Tell us

The MBA Fundlisted by The MBA Fund

How we know: press coverage · Not right? Tell us

Ulu Ventureslisted by Ulu VenturesPalo Alto · $2M

How we know: Ulu Ventures's portfolio page · a partner's Signal profile · press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

Undisclosed amountPre-SeedSep 2024
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 4

PharmEasyPharmEasy is a consumer healthcare platform offering on-demand home delivery of prescription and over-the-counter pharmaceuticals, diagnostic tests, and teleconsultation services in India.

1MgThis is a product listing page on an online pharmacy for Tugain Twins 5 Solution, a topical minoxidil-based medicine sold to treat hair loss and promote hair regrowth. The page provides usage instructions, benefits, side effects, and purchase/return details rather than describing a company.

AltibbiAltibbi is a digital health company offering telehealth and remote healthcare services, partnering with digital health organizations to serve healthcare program users. It provides telemedicine access aimed at improving the quality of remote care.

ChewyChewy is an online retailer for pet products and prescription medications, offering an Autoship subscription service and a pharmacy where licensed pharmacists coordinate with veterinarians to fill pet prescriptions. It serves pet owners with home delivery of pet supplies and medications.

Companies working in the same space as Vytala.

Frequently asked questions

What does Vytala do?: Vytala is a foodtech company that develops nutrition solutions to address fat malabsorption and other nutrient deficiencies. The company focuses on clinical nutrition with an emphasis on improving health outcomes through innovative food science.
Who founded Vytala?: Vytala was founded by Jim O'Connell in 2022.
Who are Vytala's investors?: Vytala's investors include Delaware Crossing Investor Group, Robin Hood Ventures, The MBA Fund, Ulu Ventures.